《大行報告》野村下調申洲(02313.HK)目標價至88.7元 評級「買入」
野村發表報告指,申洲國際(02313.HK)上半年收入按年下降14.9%至116億元人民幣,比市場預期低6%,淨利潤跌10.1%至21億元人民幣,較市場預期高13%。期內收入及利潤下跌主要是由於全球消費需求疫弱,導致集團產能利用率較低。
不過,該行提到,公司管理層指出利用率已開始復甦,今年第三季中國地區利用率達到逾85%以上,東南亞地區利用率達到逾95%,並預計第四季和2024年將進一步錄得改善,意味著最壞的時間已經過去。該行考慮到今年上半年的業績,將目標價由90.1元小幅下調至88.7元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.